Gautray JP, Jolivet A, Vielh JP, et al. Presence of immunoassayable beta‐endorphin in human amniotic fluid: elevation in cases of fetal distress. Am J Obstet Gynecol 1977; 129:211.465 465. Hankins GD, Rowe J, Quirk JG, Jr., et al. Significance of brown and/or green amniotic fluid at the time of second trimester genetic amniocentesis. Obstet Gynecol 1984; 64:353.
466 466. Szeto HH, Zervoudakis IA, Cederqvist LL, et al. Amniotic fluid transfer of meperidine from maternal plasma in early pregnancy. Obstet Gynecol 1978; 52:59.
467 467. Broussard CS, Rasmussen SA, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011; 204:314 e1.
468 468. Klotz U. The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications. Clin Pharmacokinet 2007; 46:271.
469 469. Jauniaux E, Gulbis B, Acharya G, et al. Maternal tobacco exposure and cotinine levels in fetal fluids in the first half of pregnancy. Obstet Gynecol 1999; 93:25.
470 470. Barr DB, Bishop A, Needham LL. Concentration of xenobiotic chemicals in the maternal–fetal unit. Reprod Toxicol 2007; 23:260.
471 471. Barr DB, Bishop A, Needham LL. Concentrations of xenobiotic chemicals in the maternal–fetal unit. Reprod Toxicol 2007; 23:260.
472 472. Ostrea EM, Jr., Matias O, Keane C, et al. Spectrum of gestational exposure to illicit drugs and other xenobiotic agents in newborn infants by meconium analysis. J Pediatr 1998; 133:513.
473 473. Bradman A, Barr DB, Claus Henn BG, et al. Measurement of pesticides and other toxicants in amniotic fluid as a potential biomarker of prenatal exposure: a validation study. Environ Health Perspect 2003; 111: 1779.
474 474. Goh YI, Chudley AE, Clarren SK, et al. Development of Canadian screening tools for fetal alcohol spectrum disorder. Can J Clin Pharmacol 2008; 15:e344.
475 475. Gray TR, Shakleya DM, Huestis MA. Quantification of nicotine, cotinine, trans‐3′‐hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 863:107.
476 476. Ostrea EM, Morales V, Ngoumgna E, et al. Prevalence of fetal exposure to environmental toxins as determined by meconium analysis. Neurotoxicology 2002; 23:329.
477 477. Custodio PJ, Carvalho ML, Nunes F, et al. Direct analysis of human blood (mothers and newborns) by energy dispersive X‐ray fluorescence. J Trace Elem Med Biol 2005; 19:151.
478 478. Turker G, Ergen K, Karakoc Y, et al. Concentrations of toxic metals and trace elements in the meconium of newborns from an industrial city. Biol Neonate 2006; 89:244.
479 479. Schmidt D, Achermann J, Odermatt B, et al. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007; 116:I64.
480 480. Sessarego N, Parodi A, Podesta M, et al. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 2008; 93:339.
481 481. Pozzobon M, Piccoli M, Schiavo AA, et al. Isolation of c‐Kit+ human amniotic fluid stem cells from second trimester. Methods Mol Biol 2013; 1035:191.
482 482. Vigeh M, Yokoyama K, Ramezanzadeh F, et al. Blood manganese concentrations and intrauterine growth restriction. Reprod Toxicol 2008; 25:219.
483 483. Osada H, Watanabe Y, Nishimura Y, et al. Profile of trace element concentrations in the feto‐placental unit in relation to fetal growth. Acta Obstet Gynecol Scand 2002; 81:931.
484 484. Sakamoto M, Kubota M, Murata K, et al. Changes in mercury concentrations of segmental maternal hair during gestation and their correlations with other biomarkers of fetal exposure to methylmercury in the Japanese population. Environ Res 2008; 106:270.
485 485. Ozdemir HS, Karadas F, Pappas AC, et al. The selenium levels of mothers and their neonates using hair, breast milk, meconium, and maternal and umbilical cord blood in Van Basin. Biol Trace Elem Res 2008; 122:206.
486 486. Tsutsumi O. Assessment of human contamination of estrogenic endocrine‐disrupting chemicals and their risk for human reproduction. J Steroid Biochem Mol Biol 2005; 93:325.
487 487. Willhite CC, Ball GL, McLellan CJ. Derivation of a bisphenol A oral reference dose (RfD) and drinking water equivalent concentration. J Toxicol Environ Health B Crit Rev 2008; 11:69.
488 488. Ostrea EM, Jr., Bielawski DM, Posecion NC, Jr., et al. A comparison of infant hair, cord blood and meconium analysis to detect fetal exposure to environmental pesticides. Environ Res 2008; 106:277.
489 489. Blount BC, Valentin‐Blasini L. Biomonitoring as a method for assessing exposure to perchlorate. Thyroid 2007; 17:837.
490 490. Wessels D, Barr DB, Mendola P. Use of biomarkers to indicate exposure of children to organophosphate pesticides: implications for a longitudinal study of children's environmental health. Environ Health Perspect 2003; 111:1939.
491 491. Whyatt RM, Barr DB, Camann DE, et al. Contemporary‐use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns. Environ Health Perspect 2003; 111:749.
492 492. Jarrell J, Chan S, Hauser R, et al. Longitudinal assessment of PCBs and chlorinated pesticides in pregnant women from Western Canada. Environ Health 2005; 4:10.
493 493. Kawashiro Y, Fukata H, Omori‐Inoue M, et al. Perinatal exposure to brominated flame retardants and polychlorinated biphenyls in Japan. Endocr J 2008; 55:1071.
494 494. Engel SM, Levy B, Liu Z, et al. Xenobiotic phenols in early pregnancy amniotic fluid. Reprod Toxicol 2006; 21:110.
495 495. Mustafa AM, Malintan NT, Seelan S, et al. Phytoestrogens levels determination in the cord blood from Malaysia rural and urban populations. Toxicol Appl Pharmacol 2007; 222:25.
496 496. Silva MJ, Reidy JA, Herbert AR, et al. Detection of phthalate metabolites in human amniotic fluid. Bull Environ Contam Toxicol 2004; 72:1226.
497 497. Huang PC, Kuo PL, Chou YY, et al. Association between prenatal exposure to phthalates and the health of newborns. Environ Int 2009; 35:14.
498 498. Milunsky A, Carmella SG, Ye M, et al. A tobacco‐specific carcinogen in the fetus. Prenat Diagn 2000; 20:307.
499 499. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004; 567:447.
500 500. Eyler FD, Behnke M, Wobie K, et al. Relative ability of biologic specimens and interviews to detect prenatal cocaine use. Neurotoxicol Teratol 2005; 27:677.
501 501. Gray T, Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem 2007; 388:1455.
502 502. Sandberg JA, Olsen GD. Microassay for the simultaneous determination of cocaine, norcocaine, benzoylecgonine and benzoylnorecgonine by high‐performance liquid chromatography. J Chromatogr 1990; 525:113.
503 503. Mastrogiannis DS, Decavalas GO, Verma U, et al. Perinatal outcome after recent cocaine usage. Obstet Gynecol 1990; 76:8.
504 504. Abdeljaber M, Nolan BM, Schork MA. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics 1990; 85:630.
505 505.
